FMR CORP 13D and 13G filings for Crinetics Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-07 10:23 am Purchase |
2025-01-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
FMR CORP | 9,631,638 10.400% |
727,552 (+8.17%) |
Filing |
| 2025-02-07 10:06 am Purchase |
2024-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
FMR CORP | 8,904,086 9.600% |
4,860,221 (+120.19%) |
Filing |
| 2024-02-09 08:50 am Purchase |
2024-02-08 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
FMR CORP | 4,043,865 6.053% |
2,160,747 (+114.74%) |
Filing |
| 2023-02-09 09:59 am Sale |
2023-02-09 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
FMR CORP | 1,883,118 3.499% |
-1,839,176 (-49.41%) |
Filing |
| 2022-01-10 1:26 pm Sale |
2022-01-07 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
FMR CORP | 3,722,294 7.836% |
-1,216,055 (-24.62%) |
Filing |
| 2021-02-08 10:19 am Purchase |
2021-02-05 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
FMR CORP | 4,938,349 14.999% |
1,305,018 (+35.92%) |
Filing |